Our analysis results revealed notably higher levels of PLVAP expression among IDH wild forms, non-codeleted 1p19q subforms, and unmethylated MGMT promoter subforms in comparison to levels in gliomas of the IDH mutation subtype (Figure 1C and D for total WHO grades; E, F for low WHO grade; G, H for high WHO grades) and the co-deleted 1p19q subform (Figure 1I and J) in combination with methylated MGMT promoter subtype (Figure 1K and L) according to the TCGA and CGGA databases. The gene discussed is PLVAP; the disease is glioma.